HHS weighs rescinding Moderna bird flu vaccine contract
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines
Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
Trump Team Weighs Pulling Funds for Moderna Bird Flu Vaccine
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.
cidrap.umn2h
COVID 2024-25 vaccines 33% protective against emergency room or urgent care visits, data reveal
Late last week in Morbidity and Mortality Weekly Report, authors from the Centers for Disease Control and Prevention (CDC) ...
STAT4d
Pharmalittle: We’re reading about a cancelled FDA vaccine meeting, a Moderna bird flu vaccine, and more
The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...
The Hill4d
HHS weighs rescinding Moderna bird flu vaccine contract
The funding review is part of a broader government push to examine spending on messenger RNA-based vaccines, the technology that Moderna and Pfizer used to develop their COVID-19 vaccines.
Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...